004720.KS
PharmGen Science, Inc.
KSC · Healthcare · Drug Manufacturers - General · KR
KRW 2,750.00
+0.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.43x
- Price / sales
- 0.34x
- Price / cash flow
- 3.48x
Enterprise value
- Enterprise value
- KRW 41.0B
- EV / sales
- 0.23x
- EV / EBITDA
- 4.78x
- EV / EBIT
- 10.52x
- Market cap
- KRW 60.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026